Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection-Reference-Cited by-同舟云学术

Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection

Published:2022-01 Issue: Volume:57 Page:103345
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Landi Doriana,Cola Gaia,Mantero Vittorio,Balgera Roberto,Moiola Lucia,Nozzolillo Agostino,Dattola Vincenzo,Sinisi Leonardo,Fantozzi Roberta,Di Lemme Sonia,Centonze Diego,Mataluni Giorgia,Nicoletti Carolina Gabri,Marfia Girolama Alessandra

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference10 articles.

1. Covid-19 in a patient with multiple sclerosis treated with natalizumab: may the blockade of integrins have a protective role?;Aguirre;Mult. Scler. Relat. Disord.,2020

2. Syndrome inflammatoire de reconstitution immune;Breton;Médecine/sciences,2010

3. Effects of COVID-19 on the nervous system;Iadecola;Cell,2020

4. Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients;Plavina;Neurology,2017

5. Duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity: when is it safe to discontinue isolation?;Rhee;Clin. Infect. Dis.,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic;Journal of Neurology;2024-06-27

2. Flu-like syndrome due to interferon-beta injections does not increase anxiety, depression, and lost working days in multiple sclerosis patients during the Sars-CoV-2 pandemic;Clinical Neurology and Neurosurgery;2023-09

3. COVID-19: The Course, Vaccination and Immune Response in People with Multiple Sclerosis: Systematic Review;International Journal of Molecular Sciences;2023-05-25

4. Relationship of patients with multiple sclerosis to vaccination against COVID-19;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023